<div class=”col-lg-9 content-page left-side”>
<section class=”section-a-single-resolutions resolutions-info top-content”>
<div class=”resolutions-contain”>
<div class=”top-content”>
<h4>Resolution Details</h4>
</div>
<div class=”bottom-content”>
<div class=”row-info”>
<strong>Company:</strong>
<p>UnitedHealth Group Inc.</p>
</div>
<div class=”row-info”>
<strong>Year:</strong>
<p>2026 </p>
</div>
<div class=”row-info”>
<strong>Issue Area:</strong>
<p>Corporate Governance </p>
</div>
<div class=”row-info”>
<strong>Focus Area:</strong>
<p>Independent Board Chairs </p>
</div>
<div class=”row-info”>
<strong>Status:</strong>
<p>Filed</p>
</div>
<div class=”row-info”>
</a>
</div>
</div>
</div>
</section>
<section class=”section-b-single-resolutions content-blocks”>
<div class=”top-content editor-block”>
<div class=”content-block”>
<div class=”main-content”>
<h2>Resolution Text</h2>
<p><strong>RESOLVED</strong>: Shareholders request that the Board of Directors adopt an enduring policy, and amend the governing documents as necessary including the Corporate Governance Guidelines in order that 2 separate people hold the office of the Chairman and the office of the CEO as soon as possible.</p>
<p><strong>SUPPORTING STATEMENT</strong>:</p>
<p dir=”ltr”>The Chairman of the Board shall be an Independent Director. An independent Lead Director shall not be a substitute for an independent Board Chairman.<br> <br>The Board shall have the discretion to select an interim Chairman of the Board, who is not an Independent Director, to serve while the Board is required to seek an Independent Chairman of the Board on an accelerated basis. This policy could be phased in when there is a contract renewal for our current CEO or for the next CEO transition although it is better to adopt it now to obtain the maximum benefit.</p>
<p dir=”ltr”>An independent Board Chairman at all times improves corporate governance by bringing impartiality, objective oversight, and external expertise to board decisions, mitigating conflicts of interest, enhancing transparency, and boosting shareholder confidence. </p>
<p dir=”ltr”>An independent Board Chairman could also help UnitedHealth (UNH) deal with future headwinds like those that emerged in 2025:</p>
<p dir=”ltr”>UNH faced significant financial setbacks, including cutting and eventually withdrawing its 2025 financial outlook, due to higher-than-expected medical costs, particularly in Medicare Advantage. These issues led to the abrupt resignation of CEO Andrew Witty in May 2025 and a significant drop in the stock price.<strong> </strong></p>
<p dir=”ltr”>Senators Ron Wyden and Elizabeth Warren launched a major investigation into UNH’s alleged incentive programs that reward nursing homes for keeping hospitalization rates below a certain threshold, even if it harms vulnerable residents. </p>
<p dir=”ltr”>The U.S. Department of Justice is conducting civil and criminal investigations into UNH for possible Medicare fraud, focusing on whether UNH and its Optum subsidiary inflated the sicknesses of Medicare Advantage members to obtain higher government payments.</p>
<p dir=”ltr”>UNH faced multiple lawsuits, including one from the California Public Employees’ Retirement System (CalPERS), which alleged UNH misled shareholders about its illegal billing schemes.</p>
<p dir=”ltr”>Following a major cyberattack in 2024 on its Change Healthcare subsidiary, UNH faced lawsuits from medical providers. The data breach affected over 190 million people.</p>
<p dir=”ltr”>A New York Times investigation revealed UHH had a widespread campaign to suppress negative information, using threats of lawsuits to force news organizations and activists to remove critical reports from Amazon and Vimeo platforms. This drew further public anger following the murder of the UNH CEO in late 2024, which sparked a broader consumer outcry over UNH practices.</p>
<p dir=”ltr”>UNH is facing scrutiny for allegedly steering patients toward its own Optum-owned facilities, a move criticized as anticompetitive. The Federal Trade Commission also sued UNH’s PBM (pharmacy benefit manager) OptumRx over practices that allegedly inflate drug prices. </p>
<p dir=”ltr”>Despite promises to ease prior authorization requirements the American Medical Association reported that little improvement had been seen.</p>
</div>
</div>
</div>
<div class=”middle-content editor-block”>
<div class=”content-block”>
<div class=”main-content”>
</div>
</div>
</div>
</section>
</div>
<aside class=”col-xl-3 right-side”>
<div class=”column-contain”>
<div class=”position-groups”>
<div class=”row bs-1col node node–type-resolution node–view-mode-resolution-filers-only”>
<div class=”col-sm-12 col-md-8 bs-region bs-region–main”>
<div class=”views-element-container form-group”>
<div class=”view view-eva view-filers view-id-filers view-display-id-entity_view_3 js-view-dom-id-d2aacb5694fcbdeb89ea8a18c1dd9a0da88a7a0b27f301957d8c27061d3350cf”>
<div class=”view-content”>
<h3>Lead Filer</h3>
<div class=”views-row”>
<div class=”views-field views-field-nothing”><span class=”field-content”> John Chevedden</span></div><div class=”views-field views-field-title views-field-field-shareholder”><span class=”field-content”>Chevedden Corporate Governance</span></div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</aside>